Search Within

Han Xiao

  1. "Body Imaging Service"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
  3. Book Section (1)
Groups
  1. Body Imaging Service (6)
  2. Department of Medicine (6)
  3. Genitourinary Oncology Service (6)
  4. Radiology, Department of (6)
  5. Solid Tumor Oncology Division (6)
  6. Epidemiology and Biostatistics (5)

More Groups

People
  1. Joshua Chaim (4)
  2. Martin Voss (4)
  3. Andrea Knezevic (3)
  4. Arlyn Apollo (3)
  5. Chung-Han Lee (3)
  6. Darren Feldman (3)

More People

Years
  1. 2024 (2)
  2. 2020 (1)
  3. 2018 (1)
  4. 2015 (1)
  5. 2013 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Atlas of Genitourinary Oncological Imaging (1)
  3. Cancer (1)
  4. European Urology Oncology (1)
  5. The Oncologist (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Elsevier BV (1)
  3. Oxford University Press (1)
  4. Springer Science + Business Media, LLC (1)
  5. Wiley Blackwell (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Bajorin, D. F.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of talazoparib and avelumab in genomically defined metastatic kidney cancer
    Journal Article

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Chaim, J.; Chen, Y.; Jacobi, R.; Zucker, M.; Reznik, E.; McHugh, D.; Shah, N. J.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial
    Journal Article

    Feldman, D. R.; Ged, Y.; Lee, C. H.; Knezevic, A.; Molina, A. M.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Murray, S.; Tickoo, S. K.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: A large single-institution experience
    Journal Article

    Bambury, R. M.; Benjamin, D. J.; Chaim, J. L.; Zabor, E. C.; Sullivan, J.; Garcia-Grossman, I. R.; Regazzi, A. M.; Ostrovnaya, I.; Apollo, A.; Xiao, H.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • General chemotherapy imaging
    Book Section

    Torrisi, J. M.; Iyriboz, T. A.; Xiao, H.
    In Bach, A. M.; Zhang, J. (Eds.) Atlas of Genitourinary Oncological Imaging (2013)

    Fulltext@MSK | Save